155 related articles for article (PubMed ID: 17618992)
1. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord.
Shoichet MS; Tator CH; Poon P; Kang C; Baumann MD
Prog Brain Res; 2007; 161():385-92. PubMed ID: 17618992
[TBL] [Abstract][Full Text] [Related]
2. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord.
Gupta D; Tator CH; Shoichet MS
Biomaterials; 2006 Apr; 27(11):2370-9. PubMed ID: 16325904
[TBL] [Abstract][Full Text] [Related]
3. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair.
Kang CE; Poon PC; Tator CH; Shoichet MS
Tissue Eng Part A; 2009 Mar; 15(3):595-604. PubMed ID: 18991489
[TBL] [Abstract][Full Text] [Related]
4. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord.
Jimenez Hamann MC; Tator CH; Shoichet MS
Exp Neurol; 2005 Jul; 194(1):106-19. PubMed ID: 15899248
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system.
Kang CE; Tator CH; Shoichet MS
J Control Release; 2010 May; 144(1):25-31. PubMed ID: 20114065
[TBL] [Abstract][Full Text] [Related]
6. An injectable drug delivery platform for sustained combination therapy.
Baumann MD; Kang CE; Stanwick JC; Wang Y; Kim H; Lapitsky Y; Shoichet MS
J Control Release; 2009 Sep; 138(3):205-13. PubMed ID: 19442692
[TBL] [Abstract][Full Text] [Related]
7. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.
Kang CE; Baumann MD; Tator CH; Shoichet MS
Cells Tissues Organs; 2013; 197(1):55-63. PubMed ID: 22796886
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.
Baumann MD; Kang CE; Tator CH; Shoichet MS
Biomaterials; 2010 Oct; 31(30):7631-9. PubMed ID: 20656347
[TBL] [Abstract][Full Text] [Related]
9. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury.
Piantino J; Burdick JA; Goldberg D; Langer R; Benowitz LI
Exp Neurol; 2006 Oct; 201(2):359-67. PubMed ID: 16764857
[TBL] [Abstract][Full Text] [Related]
10. Multiple drug delivery hydrogel system for spinal cord injury repair strategies.
Perale G; Rossi F; Santoro M; Peviani M; Papa S; Llupi D; Torriani P; Micotti E; Previdi S; Cervo L; Sundström E; Boccaccini AR; Masi M; Forloni G; Veglianese P
J Control Release; 2012 Apr; 159(2):271-80. PubMed ID: 22227024
[TBL] [Abstract][Full Text] [Related]
11. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord.
Elliott Donaghue I; Tator CH; Shoichet MS
Biomater Sci; 2015 Jan; 3(1):65-72. PubMed ID: 26214190
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord.
Sharma HS; Ali SF; Dong W; Tian ZR; Patnaik R; Patnaik S; Sharma A; Boman A; Lek P; Seifert E; Lundstedt T
Ann N Y Acad Sci; 2007 Dec; 1122():197-218. PubMed ID: 18077574
[TBL] [Abstract][Full Text] [Related]
13. Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel.
Wang Y; Lapitsky Y; Kang CE; Shoichet MS
J Control Release; 2009 Dec; 140(3):218-23. PubMed ID: 19470396
[TBL] [Abstract][Full Text] [Related]
14. The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditis.
Austin JW; Kang CE; Baumann MD; DiDiodato L; Satkunendrarajah K; Wilson JR; Stanisz GJ; Shoichet MS; Fehlings MG
Biomaterials; 2012 Jun; 33(18):4555-64. PubMed ID: 22459192
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hyaluronan-methylcellulose hydrogels for cell delivery to the injured spinal cord.
Caicco MJ; Zahir T; Mothe AJ; Ballios BG; Kihm AJ; Tator CH; Shoichet MS
J Biomed Mater Res A; 2013 May; 101(5):1472-7. PubMed ID: 23129254
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymer grafts for surgical repair of the injured spinal cord.
Friedman JA; Windebank AJ; Moore MJ; Spinner RJ; Currier BL; Yaszemski MJ
Neurosurgery; 2002 Sep; 51(3):742-51; discussion 751-2. PubMed ID: 12188954
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord blood flow and blood vessel permeability measured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factor.
Kang CE; Clarkson R; Tator CH; Yeung IW; Shoichet MS
J Neurotrauma; 2010 Nov; 27(11):2041-53. PubMed ID: 20799884
[TBL] [Abstract][Full Text] [Related]
18. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases.
Ballios BG; Cooke MJ; van der Kooy D; Shoichet MS
Biomaterials; 2010 Mar; 31(9):2555-64. PubMed ID: 20056272
[TBL] [Abstract][Full Text] [Related]
19. Click-crosslinked injectable hyaluronic acid hydrogel is safe and biocompatible in the intrathecal space for ultimate use in regenerative strategies of the injured spinal cord.
Führmann T; Obermeyer J; Tator CH; Shoichet MS
Methods; 2015 Aug; 84():60-9. PubMed ID: 25846399
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal epidermal growth factor and fibroblast growth factor-2 exacerbate meningeal proliferative lesions associated with intrathecal catheters.
Parr AM; Tator CH
Neurosurgery; 2007 May; 60(5):926-33; discussion 926-33. PubMed ID: 17460529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
